SLC18A2 and epilepsy: SLC18A2 is expressed in monoaminergic neurons of the central nervous system, and abnormal expression of SLC18A2 has been proposed to contribute to vulnerability toward epilepsy-related psychiatric disorders and cognitive impairment in adults (Markos et al., 2016; Treble-Barna et al., 2017).